000			04238nam a22003495i 4500
999			_c80350 _d80350 _x1
001			80350
003			ES-MaUEC
005			20230202102540.0
007			cr nn 008mamaa
008			140226s2014 fr | s |||| 0|eng d
020			_a9782817804309
024	7		_a10.1007/978-2-8178-0430-9 _2doi
040			_dES-MaUEC
050		4	_aRC280.D5 _bM363 2014
245	1	0	_aManagement of Neuroendocrine Tumors of the Pancreas and Digestive Tract : _bFrom Surgery to Targeted Therapies: A Multidisciplinary Approach _cedited by Eric Raymond, Sandrine Faivre, Philippe Ruszniewski.
260			_aParis _bSpringer International Publishing _c2014
300			_a1 recurso en línea (X, 236 p.) _b30 ilustraciones, 24 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aScintigraphy in Endocrine Tumors of the Gut -- Profiling the PI3K/Akt/Mtor Intracellular Pathway in Neuroendocrine Tumors -- Relevance of Angiogenesis in Neuroendocrine Tumors -- Advances with Somatostatin Analogues in Neuroendocrine Tumors: The Promise of Radionuclides in Neuroendocrine Tumors -- Streptozotocin-Based Chemotherapy is not History in Neuroendocrine Tumors -- Place of Surgical Resection in the Treatment Strategy in Neuroendocrine Tumors -- Endoscopic Resection of Gastrointestinal Neuroendocrine Tumors -- Liver-Targeting Therapies in Neuroendocrine Tumors -- Inhibition of Mtor in Neuroendocrine Tumors of the Digestive Tract -- Sunitinib in Pancreatic Neuroendocrine Tumors -- Clinical Management of Targeted Therapies in Neuroendocrine Tumors -- Imaging Tumor Response to Angiogenesis Inhibitors in Neuroendocrine Tumors -- Resistance to Targeted Therapies in Neuroendocrine Tumors -- New Anticancer Agents in Neuroendocrine Tumors -- Management of Symptoms and Patient Related Outcome Optimization in Neuroendocrine Tumors of the Digestive Tract -- Clinical Approaches of Emergencies in NET.
520			_aThis book pursues a multidisciplinary approach, presenting chapters with updated information on various aspects of treatment for patients with neuroendocrine tumors. Authors have been selected from expert centers in Europe and the United States. The goal of this book is to comprehensively summarize recent data and provide inspiring ideas to optimize the care of patients with neuroendocrine tumors. ÂYuroendocrine tumors are fascinating multifaceted diseases that can primarily localize in many organs with various presentations. These tumors are rare but their increasing incidence renders likely that physicians caring for cancers may have either already faced or may be certainly exposed to diagnose and/or treat a patient with neuroendocrine tumors. Over the last years, novel therapeutic options have emerged for neuroendocrine tumors, profoundly challenging practices that had previously been the standards for decades. These include - but are not limited to - somatostatin analogues, targeted therapies such as tyrosine kinase and mTOR inhibitors, antiangiogenic compounds, but also peptide-receptor targeted therapy or radioembolization. This changing field has generated novel treatment algorithms to guide medical decisions. To better understand and handle the multidisciplinary approaches that are required for optimizing the care of neuroendocrine tumor patients, physicians are now looking for references from experts and comprehensive reviews summarizing current knowledge on treatments for patients with neuroendocrine tumors.
700	1		_aRaymond, Eric _eeditor literario _988439 _0Local
700	1		_aFaivre, Sandrine _eeditor literario _988440 _0Local
700	1		_aRuszniewski, Philippe _eeditor literario _988441 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-2-8178-0430-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b1288103x _b10-10-17 _c11-11-15
942			_2lcc _cLE
945			_aRC280.D5 M363 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i1156085x _z06-04-17
988			_aEBSPRINGER
998			_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _gfr _h0